XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share
Basic and diluted net loss per share attributable to Class A common stockholders and Class B common stockholders (collectively, "Common Stockholders") for the years indicated was calculated as follows:
Three Months Ended
June 30,
20232022
(in thousands,
except per share and share amounts)
Net loss$(28,814)$(104,362)
Net loss attributable to Common Stockholders(28,814)(104,362)
Basic and diluted weighted average number of common shares and common share equivalents outstanding
479,163,752 476,061,809 
Net loss per share attributable to Common Stockholders—basic and diluted$(0.06)$(0.22)
Six Months Ended
June 30,
20232022
(in thousands,
except per share and share amounts)
Net loss$(101,420)$(179,852)
Net loss attributable to Common Stockholders(101,420)(179,852)
Basic and diluted weighted average number of common shares and common share equivalents outstanding
479,819,237 474,553,609 
Net loss per share attributable to Common Stockholders—basic and diluted$(0.21)$(0.38)
Schedule of Antidilutive Securities Excluded from Diluted Net Loss Per Share The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to Common Stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Three Months Ended
June 30,
20232022
Options to purchase common stock
25,504,988 27,966,433 
RSUs54,786,269 32,275,628 
PRSUs31,095,905 27,539,954 
Total anti-dilutive shares excluded from computation of net loss per share111,387,162 87,782,015 
Six Months Ended
June 30,
20232022
Options to purchase common stock
25,504,988 27,966,433 
RSUs54,786,269 32,275,628 
PRSUs31,095,905 27,539,954 
Total anti-dilutive shares excluded from computation of net loss per share111,387,162 87,782,015